Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.6800
-0.1578 (-18.84%)
At close: Aug 25, 2026, 4:00 PM EDT
0.6900
+0.0100 (1.47%)
After-hours: Aug 25, 2026, 7:59 PM EDT
Longeveron Market Cap
Longeveron has a market cap or net worth of $21.68 million as of August 25, 2026. Its market cap has increased by 78.58% in one year.
Market Cap
21.68M
Enterprise Value
12.18M
1-Year Change
78.58%
Ranking
Category
Stock Price
$0.68
ChartMarket Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $21.68M, a decrease of -87.43%. That is a compound annual growth rate of -31.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 21.68M | 100.84% |
| Dec 31, 2025 | 10.79M | -57.95% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NanoViricides | 28.93M |
| Evaxion | 28.36M |
| Quantum BioPharma | 27.61M |
| Genenta Science | 27.13M |
| Lantern Pharma | 26.97M |
| NextCure | 26.96M |
| Enlivex | 26.40M |
| Atossa Therapeutics | 26.35M |